SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-16-008321
Filing Date
2016-03-28
Accepted
2016-03-28 17:14:51
Documents
59
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm 10-K 1024784
2 ex-31.htm EX-31 12409
3 ex-32.htm EX-32 6745
4 ex3-4.htm EX-3.4 1076
5 image_001.jpg GRAPHIC 150352
  Complete submission text file 0001493152-16-008321.txt   4706133

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE lixt-20151231.xml EX-101.INS 654177
7 XBRL SCHEMA FILE lixt-20151231.xsd EX-101.SCH 61704
8 XBRL CALCULATION FILE lixt-20151231_cal.xml EX-101.CAL 43604
9 XBRL DEFINITION FILE lixt-20151231_def.xml EX-101.DEF 221716
10 XBRL LABEL FILE lixt-20151231_lab.xml EX-101.LAB 397590
11 XBRL PRESENTATION FILE lixt-20151231_pre.xml EX-101.PRE 291982
Mailing Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733
Business Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733 310 203 2902
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Filer) CIK: 0001335105 (see all company filings)

IRS No.: 202903526 | State of Incorp.: DE
Type: 10-K | Act: 34 | File No.: 000-51476 | Film No.: 161532952
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences